Abingdon Health (LON:ABDX) Announces Quarterly Earnings Results

Abingdon Health (LON:ABDX) posted its quarterly earnings data on Tuesday. The company reported GBX (0.51) EPS for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Trading Up 0.6%

Shares of ABDX traded up GBX 0.05 during midday trading on Thursday, hitting GBX 9.05. The stock had a trading volume of 571,644 shares, compared to its average volume of 237,414. The stock’s 50 day moving average is GBX 10.70 and its 200 day moving average is GBX 10.53. The firm has a market cap of £22.87 million, a PE ratio of -11.17 and a beta of 0.13. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. Abingdon Health has a 1 year low of GBX 5.50 and a 1 year high of GBX 13.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.